CompletedPhase 3NCT00033475

Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation

Studying Post-transplant lymphoproliferative disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Edinburgh
Principal Investigator
Dorothy H. Crawford, MD
University of Edinburgh
Intervention
therapeutic allogeneic lymphocytes(biological)
Enrollment
50 target
Eligibility
0-120 years · All sexes
Timeline
2001

Study locations (12)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00033475 on ClinicalTrials.gov

Other trials for Post-transplant lymphoproliferative disease

Additional recruiting or active studies for the same condition.

See all trials for Post-transplant lymphoproliferative disease →

← Back to all trials